Men line up outside the doors of the New York Narcotic Clinic in 1919 Between 1919 and 1923, clinics provided legal access to narcotics to treat addiction In 1923, Oscar Dowling brought a serious charge against a doctor in Shreveport, Louisiana. Like a headline we'd recognize today, he claimed the doctor prescribed, “indiscriminately … of … Continue reading The Morphine Maintenance Movement
Tag: United States
We Lack a United Voice in the Recovery Movement
"With the right kind of eyes you can almost see the high-water mark—that place where the wave finally broke and rolled back” – Hunter S. Thompson" Collection of 2000s recovery advocacy ephemera. (Credit: Illinois Addiction Studies Archive) This week I am attending the annual conference of the National Alliance on Recovery Residences (NARR). NARR is … Continue reading We Lack a United Voice in the Recovery Movement
Time to retire “deaths of despair”?
Source: Data Behind Americans’ Waning Trust in Institutions. The Pew Charitable Trusts. Addiction recently posted an editorial suggesting that professionals and media stop using the term "deaths of despair" because it's inaccurate, it conflates different problems, and it contributes to misunderstandings about the causes and solutions. The term ‘deaths of despair’ collates deaths caused by substance poisoning, suicide … Continue reading Time to retire “deaths of despair”?
From the Sidelines to Center Stage: Harm Reduction’s Entry into the Continuum of Care
There is a private club, known only as the “Substance Use Continuum of Care.” Membership in the club is by invitation only, and all addiction interventions in the club are legal and have federal funding. You want to be in the club, but like with any exclusive club, there are rules for members and strings … Continue reading From the Sidelines to Center Stage: Harm Reduction’s Entry into the Continuum of Care
The Unintended Consequences Of Medical “Maximalism”
The Health Affairs blog questions the American Heart Association's maximalist approach with the use of statins. The issues sound familiar. The policy implications of these guidelines are staggering. Estimates show that if these recommendations are fully implemented, close to a third of all Americans will be placed on a statin. But these developments beg the … Continue reading The Unintended Consequences Of Medical “Maximalism”
Community Recovery Capital
This weekend is the fist time I recall seeing Bill White discuss the concept of community recovery capital. I've heard him discuss community recovery and the ecology of recovery, but I think I must have missed community recovery capital. The prognosis for community recovery is influenced by the ratio between problem prevalence, severity, and complexity … Continue reading Community Recovery Capital
Drug Overdose Deaths Are Increasing Pretty Much Everywhere
These images speak for themselves. Here are a couple of important sentences: Between 1999 and 2009, drug poisoning deaths grew by 394 percent in rural areas and 279 percent for large metropolitan areas, according to the CDC’s county-level look at the data. According to the CDC, roughly 60 percent of all OD deaths in 2010 … Continue reading Drug Overdose Deaths Are Increasing Pretty Much Everywhere
What makes treatment effective?
This will be my post in response to the NY Times' series on Suboxone. This post originally ran on 7/19/13 and addressed a lot of our concerns. * * * I've been catching a lot of heat recently for posts about Suboxone and methadone. (For the sake of this post, lets refer to … Continue reading What makes treatment effective?
Addiction Treatment With a Dark Side
The NY Times has a new piece on Suboxone. First, on its blockbuster status: Suboxone is the blockbuster drug most people have never heard of. Surpassing well-known medications like Viagra and Adderall, it generated $1.55 billion in United States sales last year, its success fueled by an exploding opioid abuse epidemic and the embrace of federal officials … Continue reading Addiction Treatment With a Dark Side
Who’s guarding the hen house?
From the NY Times: Addiction experts protested loudly when the Food and Drug Administration approved a powerful new opioid painkiller last month, saying that it would set off a wave of abuse much as OxyContin did when it first appeared. An F.D.A. panel had earlier voted, 11 to 2, against approval of the drug, Zohydro, … Continue reading Who’s guarding the hen house?
